These hormonal transitions create windows of heightened sensitivity in regions involved in mood regulation. Research also ...

A new review was published in Volume 18 of Aging on May 15, 2026, titled "Blue period – features of senescence 30 years after ...

Researchers at Brigham and Women’s Hospital have identified a new class of small molecules that selectively shut down inflammatory signaling inside immune cells without disabling the body’s ability to ...

Many individuals worldwide suffer from chronic liver disease (CLD), which poses significant concerns for its tendency to lead to hepatocellular carcinoma or liver failure. CLD is characterized by ...

As research continues to expand, the dream of a healthy, inflammation-free digestive system is becoming a reality for more ...

Cannabidiol (CBD) has been shown to reduce brain inflammation in a mouse model of Alzheimer's disease. | Cannabis Sciences ...

Inflammation, a vital immune response, turns dangerous when chronic, silently damaging tissues and increasing risks of heart ...

A new review was published in Volume 18 of Aging on May 15, 2026, titled “Blue period – features of senescence 30 years after beta-galactosidase.” ...

PALM BEACH GARDENS, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Forward Therapeutics, Inc (“Forward”), a biotechnology company developing oral small molecule therapies for inflammation-driven diseases, ...

A genetics‑guided small molecule called compound 6 gently turns down an overactive immune pathway (CARD9), offering a more precise, durable, and potentially safer treatment strategy for Crohn’s ...